| Systematic (IUPAC) name | |
|---|---|
| N-(1-azabicyclo[2.2.2]octan-8-yl)-6-chloro-4-methyl-3-oxo-1,4-benzoxazine-8-carboxamide | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | Oral |
| Identifiers | |
| CAS number | 123039-99-6 |
| ATC code | None |
| PubChem | CID 2264 |
| IUPHAR ligand | 2285 |
| ChemSpider | 2177 |
| UNII | 77HC7URR9Z |
| KEGG | D07481 |
| Chemical data | |
| Formula | C17H20ClN3O3 |
| Mol. mass | 349.81 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Azasetron is an antiemetic which acts as a 5-HT3 receptor antagonist.
| This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (February 2010) |
|
||||||||||||||||||||||||||||
| This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)